AAME earnings analysis
What we found in AAME's 10-Q: the parts that mattered, the offsets in the same document, and what the company said about what comes next.
Our reading of the filing · Free to read, no account needed
Atlantic American reported essentially flat total revenue of $44,519 in Q3 2024 versus $44,591 in Q3 2023, but benefits and expenses rose to $46,973 from $42,453, producing a pre-tax loss of $(2,454) and diluted EPS of $(0.10) versus EPS of $0.08 in the year-ago quarter. Cash and cash equivalents declined to $23,035 from $28,301 at year-end, receivables increased (insurance premiums and other to $30,492 from $23,690), and operating cash flow was a use of $4,813 for the nine months. Management reiterates forward-looking disclosures and states it does not intend to sell investments and that unrealized fixed-maturity losses are largely market/interest-rate driven.
The parts that mattered.
Pulled out of the filing itself, with the figures the company reported.
- Revenue essentially flat year-over-year
- Total revenue was $44,519 in Q3 2024 versus $44,591 in Q3 2023 (down $72), showing stability in top-line premium/investment mix.
- Insurance premiums stable
- Insurance premiums, net were $43,782 in Q3 2024 compared with $43,746 in Q3 2023 (increase of $36).
- Improvement in accumulated OCI
- Accumulated other comprehensive loss improved to $(12,253) at September 30, 2024 from $(16,121) at December 31, 2023 (improvement of $3,868 during the nine months).
- No credit allowance on fixed maturities
- The Company reported no allowance for credit losses on available-for-sale fixed maturities as of September 30, 2024 and December 31, 2023 (ACL $0).
- Investment position modestly larger
- Total investments increased to $240,715 at September 30, 2024 from $237,067 at December 31, 2023 (increase of $3,648).
- Management stance on unrealized losses
- Management states unrealized losses on fixed maturities are primarily due to market interest-rate/credit spread changes and that the Company 'does not intend to sell the investments' and it's 'not more likely than not' they will be required to sell before recovery.
And the other side of it.
The offsets in the same document — the things a summary that only listed the good news would have left out.
- Operating profitability deteriorated
- Benefits and expenses increased to $46,973 in Q3 2024 from $42,453 in Q3 2023 (increase of $4,520), producing income (loss) before income taxes of $(2,454) versus income before taxes of $2,138 a year ago.
- EPS swung to a loss
- Diluted earnings per share declined to $(0.10) in Q3 2024 from $0.08 in Q3 2023 (decrease of $0.18), reflecting the operating loss and investment volatility.
- Operating cash flow remains a use of cash
- Net cash used in operating activities was $(4,813) for the nine months ended September 30, 2024 versus $(3,543) for the nine months ended September 30, 2023 (worsened by $1,270).
- Cash balance declined materially
- Cash and cash equivalents decreased to $23,035 at September 30, 2024 from $28,301 at December 31, 2023 (decline of $5,266).
- Receivables and reserves increased
- Insurance premiums and other receivables increased to $30,492 at September 30, 2024 from $23,690 at December 31, 2023 (increase of $6,802), while total insurance reserves rose to $218,882 from $212,422 (increase of $6,460).
- Significant unrealized fixed-maturity losses remain
- Gross unrealized losses on fixed maturities were $17,426 at September 30, 2024 (compared with $21,691 at December 31, 2023), representing interest-rate/credit-spread mark-to-market exposure.
What they reported.
What the company itself reported, taken out of the document.
- Earnings per share
- $-0.1
- Gross margin
- 30.9%
- Operating margin
- -3.6%
What they said about what is next.
The 10‑Q contains forward-looking statements but provides no numeric guidance; management reiterates general forward-looking disclaimers and defers quantitative outlook to earnings releases/calls.
The filing reads worse than the one before it.
What came before.
- 10-Q · May 14, 2024
- Atlantic American reported quarterly revenue of $46,997,000 (three months ended March 31, 2024), up $728,000 versus the prior-year quarter, but moved to a larger net loss and weaker margins. Gross margin (revenue less…
- 10-K · April 1, 2024
- Atlantic American positions itself as a niche-focused insurance holding company operating through two autonomous subsidiaries: American Southern (property & casualty) and Bankers Fidelity (life & health). Net earned…
- 10-Q · November 13, 2023
- Atlantic American reported Q3 2023 total revenue of $44,591,000 (down from $46,343,000 in Q3 2022) and returned to quarterly profitability with net income of $1,759,000 and diluted EPS of $0.08 versus a loss of $684,000…
- 10-K · June 30, 2023
- Atlantic American filed a delayed 2022 Form 10-K after implementing a new actuarial valuation system for its Bankers Fidelity Medicare supplement business and identified a material weakness in internal control over…
This is our reading of a public filing, not the filing. Read the original on SEC.gov · Educational only. Nothing here is investment advice.
Read the next one first.
We read every filing AAME makes the day it lands, and put it next to what the options market did about it. Members get both, and an alert when a filing arrives.
Cancel anytime · Month to month · Switch tiers whenever